4-(2-methyl-1,3-dioxolan-2-yl)piperidine, 95.0%, 1g

2-((BENZYLOXY)CARBONYL)-1-FLUOROCYCLOPROPANECARBOXYLIC ACID, 95.0%, 250mg

Manganese(II) sulphate monohydrate, min. 99%, Ph.Eur., 500 g, plastic packaging.

methyl 2-hydroxy-4-(3-methylphenyl)-4-oxobut-2-enoate, 95%, 500mg

Glass vials with rolled rim Short, 8 ml, Height, 34 mm, 154 Piece(s)

4-Methyl-5-pyridin-4-yl-4H-[1,2,4]triazole-3-thiol, 95.0%, 5g

6-bromo-8-(pyrrolidin-1-yl)-1,2,3,4-tetrahydro-1,5-naphthyridine, 95.0%, 500mg

5-Bromoisochroman, 95.0%, 500mg

N-Methyl-1,1,1-trifluoro-2-propylamine hydrochloride, 98.0%, 1g

methyl (1S,3R)-3-aminocyclopentane-1-carboxylate hydrochloride, 97, 5g

2-Methylcinnamic acid, 98%, 99.00%, 1g

1-Ethyl-3,4-dihydroisoquinoline, 96.0%, 100mg

3-[(2,3-dihydro-1H-inden-5-yloxy)methyl]benzoic acid, 95.0%, 250mg